Document is current
Any future updates will be listed below
-
Authors
Hagiu, Dragos-Paul
Tron, Arthur
Zuo, Minghui
Ecollan, Marie
Pinot, Juliette
Partouche, Henri
Gilberg, Serge
Le Bel, Josselin
Rossignol, Louise
Gauchet, Aurélie
Gagneux-Brunon, Amandine
Michel, Morgane
Mueller, Judith E.
Thilly, Nathalie
Bruel, Sébastien
-
Funding
Funding for this research was provided by:
Alliance Nationale pour les Sciences de la Vie et de la Santé
- License Information
-
More Information
Article History
Received: 17 April 2025
Accepted: 6 June 2025
First Online: 2 July 2025
Declarations
:
: This qualitative study was conducted in accordance with the ethical principles of the Declaration of Helsinki and relevant national guidelines. The alpha-testing phase received approval from the ‘CPP Sud-Est VI’ ethics committee of Clermont-Ferrand University Hospital on December 22, 2020 (ID-RCB: 2020-A02031-38, IRB00008526). The design phase, conducted as part of the broader PrevHPV project, was approved by the Inserm Institutional Review Board (IRB00003888, IORG0003254, FWA00005831) on December 10, 2019. Data were anonymized during transcription, and confidentiality was maintained throughout the process. Data collection and analysis were authorized by the French Data Protection Authority (CNIL, DR-2021-299). Participation was voluntary. Written informed consent was obtained from parents of adolescent participants for focus groups. Verbal consent was obtained and recorded for all individual interviews and for the parent focus group.
: Not applicable.
: The authors declare no competing interests.
